Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expiration
See the DrugPatentWatch profile for Evkeeza
Evkeeza is the brand name of evinacumab-dgnb, a treatment manufactured by Regeneron Pharmaceuticals (often referred to alongside its partner work at Regeneron’s facilities). [1]
Evinacumab (Evkeeza) was developed by Regeneron. [1]
Evkeeza is a branded biologic (not a small-molecule generic), so it is tied to the branded manufacturer/labeling rather than multiple interchangeable “manufacturers” in the way you might see with standard generics. [1]
The manufacturer information is listed on the FDA-approved prescribing information for Evkeeza and on the drug label. Checking the prescribing information is the most reliable way to confirm the current manufacturing/labeling details. [1] Sources: 1. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761294
Other Questions About Evkeeza :
brand name of evinacumab-dgnb